1. Treatment of endocarditis using moxifloxacin
- Author
-
John D. Perry, F.K. Gould, R. J. Koerner, H H Bain, and Andrew Berrington
- Subjects
Microbiology (medical) ,medicine.medical_specialty ,Micrococcaceae ,biology ,medicine.drug_class ,business.industry ,Conventional treatment ,General Medicine ,Staphylococcus aureus endocarditis ,medicine.disease ,Quinolone ,biology.organism_classification ,medicine.disease_cause ,Microbiology ,Surgery ,Infectious Diseases ,Moxifloxacin ,Staphylococcus aureus ,Internal medicine ,medicine ,Endocarditis ,business ,Staphylococcal endocarditis ,medicine.drug - Abstract
The conventional treatment of staphylococcal endocarditis requires in-patient administration, is inconvenient, and is potentially toxic. Increasing experience with well-absorbed, well-tolerated and highly active agents such as the new quinolones has prompted interest in their use as therapeutic alternatives for the treatment of such infections. We describe a case of staphylococcal endocarditis which failed to respond to conventional therapy, but where the addition of moxifloxacin, an 8-methoxyquinolone, was curative.
- Published
- 2001